Viewing Study NCT02421705


Ignite Creation Date: 2025-12-25 @ 3:16 AM
Ignite Modification Date: 2026-02-25 @ 8:17 PM
Study NCT ID: NCT02421705
Status: RECRUITING
Last Update Posted: 2023-02-08
First Post: 2013-07-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Visceral Sensitivity in IBD (Irritable Bowel Disease) and IBS (Irritable Bowel Syndrome)
Sponsor: KU Leuven
Organization:

Study Overview

Official Title: Visceral Sensitivity in IBD and IBS: Role of Inflammation, Immune Activity and Genetic Factors
Status: RECRUITING
Status Verified Date: 2023-02
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Aim:

More insight in pathogenesis of IBS and IBD. Samples are collected in context of an European research project.
Detailed Description: Methods:

Sample collection in healthy subjects, IBD and IBS patients:

* biopsy of rectum and colon descendens
* blood sample collection
* collection of sample of nasal mucosa
* feces collection
* questionnaires
* rectal barostat sensitivity measurement
* transit measurement of colon
* MR scan of brain

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: